These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 9464818

  • 1. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C, Le Dur A, Cholley B, Caroff M, Haeffner-Cavaillon N.
    Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
    [Abstract] [Full Text] [Related]

  • 2. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions.
    Pollack M, Ohl CA, Golenbock DT, Di Padova F, Wahl LM, Koles NL, Guelde G, Monks BG.
    J Immunol; 1997 Oct 01; 159(7):3519-30. PubMed ID: 9317151
    [Abstract] [Full Text] [Related]

  • 3. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
    Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Jun 01; 148(11):3505-12. PubMed ID: 1375247
    [Abstract] [Full Text] [Related]

  • 4. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.
    Vita N, Lefort S, Sozzani P, Reeb R, Richards S, Borysiewicz LK, Ferrara P, Labéta MO.
    J Immunol; 1997 Apr 01; 158(7):3457-62. PubMed ID: 9120307
    [Abstract] [Full Text] [Related]

  • 5. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
    Corrales I, Weersink AJ, Verhoef J, van Kessel KP.
    Immunology; 1993 Sep 01; 80(1):84-9. PubMed ID: 7503949
    [Abstract] [Full Text] [Related]

  • 6. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U, Krüger C, Schütt C.
    Circ Shock; 1993 Mar 01; 39(3):220-5. PubMed ID: 7680967
    [Abstract] [Full Text] [Related]

  • 7. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes.
    Durieux JJ, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker R, Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HW.
    Eur J Immunol; 1994 Sep 01; 24(9):2006-12. PubMed ID: 7522157
    [Abstract] [Full Text] [Related]

  • 8. Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
    Antal-Szalmás P, Poppelier MJ, Broekhuizen R, Verhoef J, van Strijp JA, van Kessel KP.
    Cytometry; 2000 Dec 01; 41(4):279-88. PubMed ID: 11084613
    [Abstract] [Full Text] [Related]

  • 9. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
    Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP, Heumann D.
    J Immunol; 1993 Jun 01; 150(11):5086-93. PubMed ID: 7684419
    [Abstract] [Full Text] [Related]

  • 10. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
    Pedron T, Girard R, Chaby R.
    J Immunol; 1995 Aug 01; 155(3):1460-71. PubMed ID: 7543522
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of recombinant bovine CD14.
    Wang Y, Zarlenga DS, Paape MJ, Dahl GE, Tomita GM.
    Vet Res; 2003 Aug 01; 34(4):413-21. PubMed ID: 12911858
    [Abstract] [Full Text] [Related]

  • 12. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI, Orr SL, Lawson EM, Soldau K, Tobias PS.
    J Immunol; 1999 May 01; 162(9):5483-9. PubMed ID: 10228028
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls.
    Medvedev AE, Flo T, Ingalls RR, Golenbock DT, Teti G, Vogel SN, Espevik T.
    J Immunol; 1998 May 01; 160(9):4535-42. PubMed ID: 9574560
    [Abstract] [Full Text] [Related]

  • 14. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
    J Lab Clin Med; 1995 May 01; 125(5):662-71. PubMed ID: 7537790
    [Abstract] [Full Text] [Related]

  • 15. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
    Couturier C, Jahns G, Kazatchkine MD, Haeffner-Cavaillon N.
    Eur J Immunol; 1992 Jun 01; 22(6):1461-6. PubMed ID: 1376258
    [Abstract] [Full Text] [Related]

  • 16. Antagonism by ethanol of endotoxin-induced tissue factor activation in relation to the depressed endotoxin binding to monocyte-like U937 cells.
    Chu AJ, Moore J, Sime R, Yu WH, Li Z.
    Cell Biochem Funct; 1997 Dec 01; 15(4):271-81. PubMed ID: 9415974
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.
    Hailman E, Vasselon T, Kelley M, Busse LA, Hu MC, Lichenstein HS, Detmers PA, Wright SD.
    J Immunol; 1996 Jun 01; 156(11):4384-90. PubMed ID: 8666811
    [Abstract] [Full Text] [Related]

  • 18. Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
    Antal-Szalmás P, Poppelier MJ, Sümegi A, van der Bruggen T, Verhoef J, van Kessel KP, van Strijp JA.
    Immunol Lett; 2004 Apr 30; 93(1):11-5. PubMed ID: 15134893
    [Abstract] [Full Text] [Related]

  • 19. Binding sites for endotoxins (lipopolysaccharides) on human monocytes.
    Couturier C, Haeffner-Cavaillon N, Caroff M, Kazatchkine MD.
    J Immunol; 1991 Sep 15; 147(6):1899-904. PubMed ID: 1716284
    [Abstract] [Full Text] [Related]

  • 20. Modulation of lipopolysaccharide binding to human granulocytes.
    Weersink AJ, Van Kessel KP, Van der Tol ME, Verhoef J.
    Immunology; 1994 Dec 15; 83(4):617-23. PubMed ID: 7533136
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.